12-31-2022
INR/share | |
Price | 1,001.40 |
Dividend | 10.01 |
Earnings | 17.57 |
Cash-flow | 38.22 |
Book value | 200.28 |
Equity | 197.42 |
Sun Pharmaceuticals is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Sun Pharmaceuticals is a company from India, and his stocks are publicly traded.
Sun Pharmaceuticals paid a total dividend of 24,014 million INR last year, for a market value of 2,402,359 millions (Market Cap 1,088,676 millions). Dividend per share of Sun Pharmaceuticals is 10.01 INR, and his stock market price 1,001.40 INR.
According to the chart below, where dividend yield is displayed, Sun Pharmaceuticals has a dividend yield of 1.00%, lower than the amount offered by both the market average and companies from India. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Sun Pharmaceuticals dividend yield with other Pharmaceuticals and Biotechnology companies or firms from India.
Sun Pharmaceuticals Dividend Payout
About the ability of Sun Pharmaceuticals to maintain his current dividend of INR 10.01 per share, an amount that accounts for 1.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Sun Pharmaceuticals payout on ernings is currently 56.97%, which is higher than the market average, and companies of Health Care industry, which are 41.22% and 34.13% respectively. Both figures show that Sun Pharmaceuticals can have problems to keep with his present dividend yield.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Sun Pharmaceuticals is INR 38.22 per share, which is higher than the dividend per share paid by the company of INR 10.01, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Sun Pharmaceuticals, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Sun Pharmaceuticals Dividend History
Year | Yield | INR | Paypout | Shares* |
Present | 1.00% | 10.01 | 56.97% | 2,399 |
2021 | 0.89% | 7.53 | 48.36% | 2,399 |
2020 | 0.17% | 1.01 | 5.13% | 2,399 |
2019 | 0.64% | 2.77 | 19.73% | 2,399 |
2018 | 0.46% | 1.98 | 16.46% | 2,399 |
2017 | 0.61% | 3.48 | 11.33% | 2,399 |
2016 | 0.14% | 0.99 | 4.81% | 2,408 |
2015 | 0.41% | 2.99 | 15.33% | 2,408 |
*In millions
Sun Pharmaceuticals Stock performance
Finally, last moth Sun Pharmaceuticals showed a return of -4.30% compared to a worldwide -2.30% average, and a -1.20% of Health Care firms. Over the last year, the company obtained a 18.40% versus a worldwide performance of a -5.85%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.